دورية أكاديمية

Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.

التفاصيل البيبلوغرافية
العنوان: Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift.
المؤلفون: Plum J; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark., Bavnhøj CG; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark., Eliasen JN; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark., Rades T; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark. Electronic address: thomas.rades@sund.ku.dk., Müllertz A; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark; Bioneer:FARMA, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
المصدر: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2020 Jul; Vol. 152, pp. 35-43. Date of Electronic Publication: 2020 May 04.
نوع المنشور: Comparative Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier Science
Original Publication: Stuttgart : Wissenschaftliche Verlagsgesellschaft, c1991-
مواضيع طبية MeSH: Pharmaceutical Preparations/*chemistry , Solvents/*chemistry , Technology, Pharmaceutical/*methods, Excipients/chemistry ; Hypromellose Derivatives/chemistry ; Polymers/chemistry ; Povidone/chemistry ; Solubility
مستخلص: Simple solvent shift is often used to induce supersaturation and investigate precipitation kinetics in early drug development as a substitute for amorphous dissolution. This study develops and compares a small-scale non-sink amorphous dissolution method to a solvent shift method as induction methods for supersaturation of the model drugs albendazole, felodipine and tadalafil with respect to the maximum dissolved drug concentration, and the solid form of the precipitate. The study also investigates the effect of pre-dispersed precipitation inhibitors (hydroxypropyl methyl cellulose (HPMC) or polyvinylpyrrolidone (PVP)) on tadalafil supersaturation induced by both amorphous dissolution and solvent shift with respect to maximum dissolved drug concentration, precipitation rate and solid form of the precipitate. The maximum drug concentrations achieved through solvent shift were 15.9, 208 and 108 µg/mL for albendazole, felodipine and tadalafil, respectively. Pre-dispersing 0.1% (w/v) HPMC or PVP, increased the maximum concentration by solvent shift of tadalafil to 180 µg/mL, for both polymers. Dissolution of up to 90 mg albendazole, 120 mg felodipine and 8.9 mg tadalafil could yield a maximum dissolved drug concentration of 76.1%, 87.9% and 102.5%, respectively, of the corresponding solvent shift maximum concentration. The maximum concentration achieved through amorphous dissolution of tadalafil with HPMC or PVP present in the dissolution medium was 87.1% and 88.7%, respectively of the solvent shift maximum concentration. Dissolution of 2 mg amorphous tadalafil with and without pre-dispersed polymer gave the same rank order of onset of precipitation as for the solvent shift method. The solid form of precipitate was the same for albendazole, felodipine, tadalafil and tadalafil with PVP for both methods. For tadalafil with HPMC, the precipitate was amorphous following solvent shift, but crystalline after amorphous dissolution. Overall, this study shows that the maximum concentration achievable through amorphous dissolution can be estimated when performing solvent shift and the precipitation inhibition of excipients assessed via solvent shift can be used to predict the effect on precipitation using amorphous dissolution.
(Copyright © 2020 Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: Amorphous; Dissolution; Precipitation inhibitors; Supersaturation
المشرفين على المادة: 0 (Excipients)
0 (Pharmaceutical Preparations)
0 (Polymers)
0 (Solvents)
3NXW29V3WO (Hypromellose Derivatives)
FZ989GH94E (Povidone)
تواريخ الأحداث: Date Created: 20200508 Date Completed: 20210205 Latest Revision: 20210205
رمز التحديث: 20240628
DOI: 10.1016/j.ejpb.2020.04.017
PMID: 32376371
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-3441
DOI:10.1016/j.ejpb.2020.04.017